Cryoport (NASDAQ:CYRX) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Cryoport (NASDAQ:CYRX) posted its quarterly earnings results on Tuesday. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.09), Zacks reports. Cryoport had a negative return on equity of 13.35% and a negative net margin of 70.08%. Cryoport updated its FY 2025 guidance to EPS.

Cryoport Stock Performance

Cryoport stock traded up $0.26 during midday trading on Tuesday, hitting $5.06. The company’s stock had a trading volume of 960,643 shares, compared to its average volume of 285,872. The company has a debt-to-equity ratio of 0.48, a current ratio of 5.70 and a quick ratio of 5.32. The company has a market cap of $250.12 million, a price-to-earnings ratio of -1.50 and a beta of 1.59. Cryoport has a 1-year low of $4.58 and a 1-year high of $20.10. The company has a 50-day moving average price of $7.39 and a two-hundred day moving average price of $7.65.

Wall Street Analysts Forecast Growth

CYRX has been the subject of several research analyst reports. Needham & Company LLC reiterated a “buy” rating and set a $11.00 target price on shares of Cryoport in a research note on Friday, January 17th. Roth Mkm reduced their price objective on shares of Cryoport from $18.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Finally, Guggenheim assumed coverage on shares of Cryoport in a research report on Thursday, December 19th. They issued a “buy” rating and a $11.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Cryoport presently has an average rating of “Moderate Buy” and a consensus target price of $12.29.

Cryoport Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.